Evidence map›Paper›PMID 38233843›Full record

ArticleMicrobial cell factories2024

Refining and illuminating acetogenic Eubacterium strains for reclassification and metabolic engineering.

Maximilian Flaiz, Anja Poehlein, Wiebke Wilhelm, Alexander Mook, Rolf Daniel, Peter Dürre, Frank R Bengelsdorf

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Maximilian FlaizLaboratory of Microbiology, Wageningen University and Research, Wageningen, The Netherlands. maximilian.flaiz@wur.nl.ORCID http://orcid.org/0000-0003-0238-4995
Anja PoehleinGenomic and Applied Microbiology & Göttingen Genomics Laboratory, Georg-August University, Göttingen, Germany.ORCID http://orcid.org/0000-0002-2473-6202
Wiebke WilhelmInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.ORCID http://orcid.org/0009-0007-8561-4341
Alexander MookInstitute of Molecular Biology and Biotechnology of Prokaryotes, University of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0003-0834-3780
Rolf DanielGenomic and Applied Microbiology & Göttingen Genomics Laboratory, Georg-August University, Göttingen, Germany.ORCID http://orcid.org/0000-0002-8646-7925
Peter DürreInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0002-5586-221X
Frank R BengelsdorfInstitute of Molecular Biology and Biotechnology of Prokaryotes, University of Ulm, Ulm, Germany. frank.bengelsdorf@uni-ulm.de.ORCID http://orcid.org/0000-0003-3802-9485
Universität Ulm · DEUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe genus Eubacterium is quite diverse and includes several acetogenic strains capable of fermenting C1-substrates into valuable products. Especially, Eubacterium limosum and closely related strains attract attention not only for their capability to ferment C1 gases and liquids, but also due to their ability to produce butyrate. Apart from its well-elucidated metabolism, E. limosum is also genetically accessible, which makes it an interesting candidate to be an industrial biocatalyst.

resultsIn this study, we examined genomic, phylogenetic, and physiologic features of E. limosum and the closest related species E. callanderi as well as E. maltosivorans. We sequenced the genomes of the six Eubacterium strains 'FD' (DSM 3662

conclusionStrains of E. limosum, E. callanderi, and E. maltosivorans are outstanding candidates as biocatalysts for anaerobic C1-substrate conversion into valuable biocommodities. A large variety of strains is genetically accessible using a harmonized electroporation protocol, and FAST can serve as a reliable fluorescent reporter protein to characterize genetically engineered cells. In total eleven strains have been assigned to distinct clades, providing a clear and updated classification. Thus, the description of respective Eubacterium species has been emended, improved, aligned, and is requested to be implemented in respective databases.

Indexed as

EubacteriumMetabolic EngineeringButyratesMethanolPhylogenyButyratesMethanolAcetogensAnaerobescallanderiEubacteriumFASTFluorescenceHexanoatelimosummaltosivoransMethanol

Identifiers

PMID38233843
PMCPMC10795377
OpenAlexW4390935791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.